Lilly Novo Nordisk Battle Intensifies as Obesity Drugs Surge
Eli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Explore various ways to grow wealth with low risk that can help you achieve financial security. Start making informed investment choices today.
27,305 articlesEli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Texas is attracting corporate headquarters, talent and capital at a pace unseen in years, redefining where investors ...
Brokerages report wide AI use, but agents say the payoff isn’t consistently converting to more closings. A 2026 snaps...
Goldman Sachs data reveal a rapid major shift as college students voting with AI concerns reshape the 2025-26 academi...
The FDA confirms a national shortage of needles used detect breast after a recall. Hospitals warn the gap could delay...
Singapore's companies dominate the Southeast Asia 500 by revenue, capturing roughly a third of the region's total. Th...
Pi Network shows resilience as the protocol upgrade cycle continues. The token rebounds from a key $0.13 support leve...
A fresh OpenAI policy hire has warned that government monopoly over frontier AI testing could slow innovation and rai...
XRP faces a stubborn warning signal even as large holders slow their moves to Binance. With momentum fading and key l...
Ripple won a preliminary CASP license from Luxembourg under MiCA, a key step in its EU expansion. The license is not ...
Semiconductors led by the SMH and SOXX pulled back sharply, triggering fresh talk of a buyable dip. Famous tech inves...
Bank of America says Micron Technology is trading at a sub-10x forward multiple despite a structural shift toward AI-...